- Collaboration agreement with Neurosurgery Department of
Karolinska University Hospital will further enhance the usage of
the company's transformative IRRAflow system to benefit
neurocritical care patients in Sweden
- Karolinska University Hospital is one of Scandinavia's
premier health facilities and one of Europe's largest teaching hospitals
STOCKHOLM, Jan. 12, 2021 /PRNewswire/ -- IRRAS AB, a
commercial-stage medical technology company with a comprehensive
portfolio of innovative products for neurocritical care, today
announced a collaboration agreement with Karolinska University
Hospital, a world-class clinical facility, that includes the
initiation of an evaluation of IRRAflow, the company's lead
commercial product.
Peter Alpkvist, Neurosurgeon and head of Neurosurgical Intensive
Care Unit (NICU) at Karolinska University Hospital, comments, "We
are excited to bring an innovative, next-generation solution for
the treatment of intracranial bleeding to our neurocritical care
patients."
"We are pleased and excited to have this collaboration agreement
executed and look forward to having the world's first irrigating
ventricular drainage system available to the clinical team at the
neurosurgery department of Karolinska University Hospital," said
Coenraad Tamse, Vice President of
International Sales at IRRAS.
"This partnership allows us to accelerate commercial launches in
the Nordic region while working closely with a leading facility and
clinical experts," added Edmond
Malek, IRRAS' Nordic Country Sales Head.
About Karolinska University Hospital
Karolinska University Hospital is one of Scandinavia's premier
health facilities and one of Europe's largest teaching hospitals. Their
services encompass health care for disorders ranging from major
public health diseases to rare medical conditions. In the
Stockholm region, they are a
designated provider of highly specialized medical services.
Karolinska University Hospital also serve many patients from other
parts of Sweden and from other
countries around the world. As the county council's teaching
hospital, Karolinska University Hospital has a primary
responsibility for the clinical components of research and
education. Together with the world-respected Karolinska Institutet, they lead in medical
breakthroughs in Sweden. They
believe that patient care, research, and education must all play
equally strong roles in its effort to extend and enhance people's
lives. As a major teaching hospital they educate and train
tomorrow's medical specialists and healthcare professionals.
About IRRAS
IRRAS is a global medical care company focused on delivering
innovative medical solutions to improve the lives of critically ill
patients. IRRAS designs, develops, and commercializes neurocritical
care products that transform patient outcomes and decrease the
overall cost of care by addressing complications associated with
current treatment methodologies. IRRAS markets and sells its
comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring
product lines to hospitals worldwide through its direct sales
organization in the United States
and select European countries as well as an international network
of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
USA
Kleanthis G. Xanthopoulos,
Ph.D.
CEO
ir@irras.com
Europe
Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on January 12, 2021 at 08:00 (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/irras-announces-collaboration-with-karolinska-university-hospital,c3266320